Ken Cohen, MD, FACP

home / authors / ken-cohen-md-facp

Articles

March 14th 2025

Davida Kruger, MSN, APN-BC, BC-ADM Jaime Murillo, MD, FACC, FASE Ian Neeland, MD, FAHA, FACC Ken Cohen, MD, FACP Jeremy Wigginton, MD, MBA, FAAFP

This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss how continuous glucose monitoring (CGM) adoption impacts clinical inertia and supports earlier therapeutic interventions across different patient populations, highlighting measurable improvements in patient outcomes, such as glycemic control, hemoglobin A1c (HbA1c) levels, hypoglycemic events, and quality of life.

March 14th 2025

Key Benefits of CGM Technology

Davida Kruger, MSN, APN-BC, BC-ADM Jaime Murillo, MD, FACC, FASE Ian Neeland, MD, FAHA, FACC Ken Cohen, MD, FACP Jeremy Wigginton, MD, MBA, FAAFP

This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss the key benefits of continuous glucose monitoring (CGM) technology compared with traditional monitoring based on recent clinical trial data, including research on cardiovascular-risk reduction in noninsulin patients.